| Result of AGM | 11-May-2012 | 12:32 | RNS |
| 2011 Annual Report and Notice of AGM | 10-Apr-2012 | 07:00 | RNS |
| Final Results | 20-Mar-2012 | 07:00 | RNS |
| Novel c-Met inhibitor Volitinib Enters the Clinic | 22-Feb-2012 | 07:00 | RNS |
| Notice of Results | 20-Feb-2012 | 07:00 | RNS |
| Holding(s) in Company | 14-Feb-2012 | 08:07 | RNS |
| Total Voting Rights | 02-Feb-2012 | 07:00 | RNS |
| Holding(s) in Company | 05-Jan-2012 | 10:49 | RNS |
| Blocklisting Six Monthly Return | 29-Dec-2011 | 07:00 | RNS |
| CANCER THERAPY COLLABORATION WITH ASTRAZENECA | 21-Dec-2011 | 07:00 | RNS |
| Chi-Med Loan Facility | 12-Dec-2011 | 07:00 | RNS |
| Initiates Epitinib Phase I clinical study | 04-Nov-2011 | 07:00 | RNS |
| Holding(s) in Company | 05-Sep-2011 | 07:00 | RNS |
| Interim Results | 01-Aug-2011 | 07:00 | RNS |
| China Healthcare Division expansion | 22-Jul-2011 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 427.50p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 470.00p |
| 52 Week Low | 263.00p |
| Volume | 2,454 |
| Shares Issued | 51.79m |
| Market Cap | £221.42m |
| Beta | 0.26 |
| RiskGrade | 160 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 2 |
| Buy | 0 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 4 |

| No dividends found |
| Time | Volume / Share Price |
| 13:21 | 1,034 @ 435.00p |
| 13:07 | 1 @ 420.00p |
| 12:37 | 1,384 @ 429.75p |
| 08:20 | 35 @ 435.00p |
You are here: research